MUNDIPHARMA will become the exclusive Japanese distributor of Norspan Tape from 28 Feb 2019, under an agreement with Hisamitsu Pharmaceutical, which will cease selling the product.
In 2011 Mundipharma acquired the marketing approval of Norspan, which is a dermally absorbed buprenorphine adhesive agent, and has now fully developed its distribution infrastructure in Japan, leading to the change.
The above article was sent to subscribers in Pharmacy Daily's issue from 12 Dec 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 12 Dec 18
